Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2013 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study.
Turnsek N, Devjak R, Edelbaher N, Osrajnik I, Unk M, Vidovic D, Jeric T, Janzic U. Turnsek N, et al. Among authors: jeric t. Radiol Oncol. 2022 Aug 14;56(3):371-379. doi: 10.2478/raon-2022-0025. Radiol Oncol. 2022. PMID: 35853681 Free PMC article.